| Full Name | Dylan C Wyatt |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 7 Years |
| Location | 915 E 1st St, Duluth, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295269389 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 68087 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Lukes Hospital | Duluth, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Lukes Hospital Of Duluth | 7113834839 | 352 |
News Archive
Researchers at the Virginia Bioinformatics Institute at Virginia Tech have developed a new large animal model to study how the immune system interacts with the stomach bacterium Helicobacter pylori, the leading cause of peptic ulcer disease.
Experts believe that where on the body people store surplus fat, whether round their middle or round the liver, may be genetically determined.
Hepatocellular carcinoma is a long medical name for the most common form of liver cancer, a malignancy whose incidence has nearly doubled over the past decade, making it the fastest growing type of cancer in the U.S., and the third-leading cause of cancer-related death worldwide.
PharmaEssentia Corporation announces presentation of the results of the phase II trial for P1101 + ribavirin in patients with chronic HCV genotype 1 infection at the 25th Conference of the Asian Pacific Association for the Study of the Liver, taking place in Tokyo, Japan from February 20 to 24, 2016 (APASL 2016). Data will be presented by the study coordinating investigator Prof. Wan-Long Chuang (Taiwan) at the HCV parallel oral session on Feb 22nd (15:45-17:45).
› Verified 8 days ago
| Entity Name | St Lukes Hospital Of Duluth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902845068 PECOS PAC ID: 7113834839 Enrollment ID: O20031120000212 |
News Archive
Researchers at the Virginia Bioinformatics Institute at Virginia Tech have developed a new large animal model to study how the immune system interacts with the stomach bacterium Helicobacter pylori, the leading cause of peptic ulcer disease.
Experts believe that where on the body people store surplus fat, whether round their middle or round the liver, may be genetically determined.
Hepatocellular carcinoma is a long medical name for the most common form of liver cancer, a malignancy whose incidence has nearly doubled over the past decade, making it the fastest growing type of cancer in the U.S., and the third-leading cause of cancer-related death worldwide.
PharmaEssentia Corporation announces presentation of the results of the phase II trial for P1101 + ribavirin in patients with chronic HCV genotype 1 infection at the 25th Conference of the Asian Pacific Association for the Study of the Liver, taking place in Tokyo, Japan from February 20 to 24, 2016 (APASL 2016). Data will be presented by the study coordinating investigator Prof. Wan-Long Chuang (Taiwan) at the HCV parallel oral session on Feb 22nd (15:45-17:45).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dylan C Wyatt, 915 E 1st St, Duluth, MN 55805-2107 Ph: (218) 249-5555 | Dylan C Wyatt, 915 E 1st St, Duluth, MN 55805-2107 Ph: (218) 249-5555 |
News Archive
Researchers at the Virginia Bioinformatics Institute at Virginia Tech have developed a new large animal model to study how the immune system interacts with the stomach bacterium Helicobacter pylori, the leading cause of peptic ulcer disease.
Experts believe that where on the body people store surplus fat, whether round their middle or round the liver, may be genetically determined.
Hepatocellular carcinoma is a long medical name for the most common form of liver cancer, a malignancy whose incidence has nearly doubled over the past decade, making it the fastest growing type of cancer in the U.S., and the third-leading cause of cancer-related death worldwide.
PharmaEssentia Corporation announces presentation of the results of the phase II trial for P1101 + ribavirin in patients with chronic HCV genotype 1 infection at the 25th Conference of the Asian Pacific Association for the Study of the Liver, taking place in Tokyo, Japan from February 20 to 24, 2016 (APASL 2016). Data will be presented by the study coordinating investigator Prof. Wan-Long Chuang (Taiwan) at the HCV parallel oral session on Feb 22nd (15:45-17:45).
› Verified 8 days ago
Blake Ervin Collison, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 407 E 3rd St, Duluth, MN 55805 Phone: 218-786-4000 | |
Dr. Gregory K Bernhardt, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 915 E 1st St, Duluth, MN 55805 Phone: 218-249-5616 | |
Dr. Colton David Wiesner, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 402 E 2nd St, Duluth, MN 55805 Phone: 218-786-4000 | |
Dr. Wendell Rhett Bonner, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4212 Grand Ave, Duluth, MN 55807 Phone: 218-786-3500 | |
Dr. Erika M Miles, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 407 East 3rd Street, St. Mary's Medical Center, Duluth, MN 55805 Phone: 218-786-4357 | |
Dr. Timothy E Borden, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 East Third Street, Essentia Health Duluth Clinic, Duluth, MN 55805 Phone: 218-786-8364 | |
Dr. Dalton Grimm, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 915 E 1st St, Duluth, MN 55805 Phone: 218-249-5555 |